These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 34257565)
21. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857 [TBL] [Abstract][Full Text] [Related]
22. Expression of cyclo-oxygenase-2 and yap/taz in hepatocellular carcinoma in untreated and treated hepatitis C virus patients. Sweed D; Abd-Elbary A; Sweed E; Mosbeh A; Moaz I; Yassein T; Elmashad S Pol J Pathol; 2022; 73(2):88-98. PubMed ID: 35979755 [TBL] [Abstract][Full Text] [Related]
23. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis. Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500 [TBL] [Abstract][Full Text] [Related]
24. SEPTIN10-mediated crosstalk between cytoskeletal networks controls mechanotransduction and oncogenic YAP/TAZ signaling. Weiler SME; Bissinger M; Rose F; von Bubnoff F; Lutz T; Ori A; Schirmacher P; Breuhahn K Cancer Lett; 2024 Mar; 584():216637. PubMed ID: 38242197 [TBL] [Abstract][Full Text] [Related]
25. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907 [TBL] [Abstract][Full Text] [Related]
26. A spatial model of YAP/TAZ signaling reveals how stiffness, dimensionality, and shape contribute to emergent outcomes. Scott KE; Fraley SI; Rangamani P Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33990464 [TBL] [Abstract][Full Text] [Related]
27. The calcimimetic agent cinacalcet inhibits hepatocellular carcinoma via YAP/TAZ suppression. Zheng L; Du J; Ge F; Qian M; Yang B; He Q; Weng Q; Zhu H Pharmazie; 2021 Oct; 76(10):511-514. PubMed ID: 34620281 [TBL] [Abstract][Full Text] [Related]
28. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. Luo J; Zou H; Guo Y; Tong T; Chen Y; Xiao Y; Pan Y; Li P Br J Cancer; 2023 May; 128(9):1611-1624. PubMed ID: 36759723 [TBL] [Abstract][Full Text] [Related]
29. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related]
30. YAP/TAZ axis was involved in the effects of metformin on breast cancer. Xu Y; Cai H; Xiong Y; Tang L; Li L; Zhang L; Shen Y; Yang Y; Lin L; Huang J J Chemother; 2023 Nov; 35(7):627-637. PubMed ID: 36656142 [TBL] [Abstract][Full Text] [Related]
31. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. Kim GJ; Kim H; Park YN PLoS One; 2013; 8(9):e75449. PubMed ID: 24086533 [TBL] [Abstract][Full Text] [Related]
32. A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development. Cha B; Moon S; Kim W BMB Rep; 2021 Jun; 54(6):285-294. PubMed ID: 33691907 [TBL] [Abstract][Full Text] [Related]
33. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment. Wang XL; Xian Y; Chen XL Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219 [TBL] [Abstract][Full Text] [Related]
34. Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways. Moon H; Park H; Chae MJ; Choi HJ; Kim DY; Ro SW BMC Cancer; 2022 Apr; 22(1):423. PubMed ID: 35439973 [TBL] [Abstract][Full Text] [Related]
35. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036 [TBL] [Abstract][Full Text] [Related]
36. SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ. Yuan T; Zhou T; Qian M; Du J; Liu Y; Wang J; Li Y; Fan G; Yan F; Dai X; Li X; Wu Y; Dong X; He Q; Zhu H; Yang B Hepatology; 2023 Jul; 78(1):103-119. PubMed ID: 35713976 [TBL] [Abstract][Full Text] [Related]
37. Roles and mechanisms of YAP/TAZ in orthodontic tooth movement. Deng L; Chen Y; Guo J; Han X; Guo Y J Cell Physiol; 2021 Nov; 236(11):7792-7800. PubMed ID: 33843049 [TBL] [Abstract][Full Text] [Related]
38. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ. Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697 [TBL] [Abstract][Full Text] [Related]
39. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404 [TBL] [Abstract][Full Text] [Related]
40. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop. Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]